Form Type: 4

SEC EDGAR Link
Accession Number:0001562180-20-005100
Date:2020-07-08
Issuer: BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. (BHVN)
Original Submission Date:

Reporting Person:

BERMAN ROBERT
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET NEW HAVEN, CT 06510

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON SHARES 2020-07-08 M 58,404 a $0.61 58,745 direct
COMMON SHARES 2020-07-08 S 55,626 d $75.25 3,119 direct
COMMON SHARES 2020-07-08 S 2,778 d $75.29 341 direct
COMMON SHARES 2020-07-08 0 $0.00 550,000 indirect
COMMON SHARES 2020-07-08 0 $0.00 240,500 indirect
COMMON SHARES 2020-07-08 0 $0.00 50 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 0.61 2020-07-08 deemed execution date M 58,404 (d) 2024-11-25 common shares 58,404 $0.61 0 direct
Footnotes
IDfootnote
f1 these exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the reporting person.
f2 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $75.00 - $75.95, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this form 4.
f3 the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $76.00 - $76.22, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this form 4.
f4 the option, representing a right to purchase a total of 225,000 shares, was granted on november 26, 2014, and vested in four equal installments on november 26, 2014, 2015, 2016 and 2017
WhaleWisdom Logo

Elevate your investments